EOLS – Evolus, Inc.
Evolus, Inc. Common StockEOLS
$6.65Name : Evolus, Inc. Common Stock
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $431,051,584.00
EPSttm : -0.9
Evolus, Inc. Common Stock
$6.65
0.30%$0.02Float Short %
12.78
Margin Of Safety %
Put/Call OI Ratio
0.04
EPS Next Q Diff
0.13
EPS Last/This Y
0.42
EPS This/Next Y
0.56
Price
6.67
Target Price
18.5
Analyst Recom
1.29
Performance Q
8.13
Relative Volume
0.86
Beta
0.91
Ticker: EOLS
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-02 | EOLS | 6.53 | 0.03 | 0.08 | 8705 |
| 2025-12-03 | EOLS | 6.75 | 0.03 | 0.03 | 8724 |
| 2025-12-04 | EOLS | 6.83 | 0.03 | 3.64 | 8754 |
| 2025-12-05 | EOLS | 6.86 | 0.04 | 0.00 | 8752 |
| 2025-12-08 | EOLS | 6.98 | 0.03 | 0.00 | 8793 |
| 2025-12-09 | EOLS | 6.99 | 0.03 | 0.00 | 8804 |
| 2025-12-10 | EOLS | 7.1 | 0.03 | 0.00 | 8809 |
| 2025-12-11 | EOLS | 6.92 | 0.03 | 0.02 | 8864 |
| 2025-12-12 | EOLS | 7.05 | 0.03 | 0.00 | 8866 |
| 2025-12-15 | EOLS | 7.15 | 0.03 | 0.00 | 8954 |
| 2025-12-16 | EOLS | 7.22 | 0.03 | 0.59 | 8893 |
| 2025-12-17 | EOLS | 7.09 | 0.03 | 0.00 | 8891 |
| 2025-12-18 | EOLS | 7.18 | 0.03 | 0.15 | 8872 |
| 2025-12-19 | EOLS | 7.05 | 0.03 | 0.00 | 8823 |
| 2025-12-22 | EOLS | 7.18 | 0.03 | 0.00 | 7951 |
| 2025-12-23 | EOLS | 6.82 | 0.03 | 0.00 | 7961 |
| 2025-12-26 | EOLS | 6.91 | 0.03 | 0.00 | 7975 |
| 2025-12-29 | EOLS | 6.66 | 0.03 | 5.45 | 8083 |
| 2025-12-30 | EOLS | 6.66 | 0.04 | 0.00 | 8149 |
| 2025-12-31 | EOLS | 6.66 | 0.04 | 0.02 | 8231 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-02 | EOLS | 6.52 | 302.9 | 36.6 | -0.39 |
| 2025-12-03 | EOLS | 6.75 | 302.9 | 36.5 | -0.39 |
| 2025-12-04 | EOLS | 6.82 | 302.9 | 36.5 | -0.39 |
| 2025-12-05 | EOLS | 6.85 | 302.9 | 36.5 | -0.39 |
| 2025-12-08 | EOLS | 6.97 | 302.9 | - | -0.39 |
| 2025-12-09 | EOLS | 6.98 | 302.9 | 36.6 | -0.39 |
| 2025-12-10 | EOLS | 7.09 | 302.9 | 36.5 | -0.39 |
| 2025-12-11 | EOLS | 6.92 | 302.9 | 36.6 | -0.39 |
| 2025-12-12 | EOLS | 7.05 | 302.9 | 36.5 | -0.39 |
| 2025-12-15 | EOLS | 7.14 | 302.9 | 36.5 | -0.39 |
| 2025-12-16 | EOLS | 7.14 | 302.9 | 36.6 | -0.39 |
| 2025-12-17 | EOLS | 7.10 | 302.9 | 36.6 | -0.39 |
| 2025-12-18 | EOLS | 7.18 | 302.9 | 36.5 | -0.39 |
| 2025-12-19 | EOLS | 7.05 | 302.9 | 36.6 | -0.39 |
| 2025-12-22 | EOLS | 7.14 | 302.9 | 36.5 | -0.39 |
| 2025-12-23 | EOLS | 6.80 | 302.9 | 36.6 | -0.39 |
| 2025-12-26 | EOLS | 6.91 | 302.9 | 36.5 | -0.39 |
| 2025-12-29 | EOLS | 6.66 | 302.9 | 36.6 | -0.39 |
| 2025-12-30 | EOLS | 6.66 | 302.9 | 36.6 | -0.39 |
| 2025-12-31 | EOLS | 6.67 | 302.9 | 36.6 | -0.39 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-02 | EOLS | -0.55 | -9.23 | 22.72 |
| 2025-12-03 | EOLS | -0.55 | -9.23 | 22.72 |
| 2025-12-04 | EOLS | -0.55 | -9.23 | 22.72 |
| 2025-12-05 | EOLS | -0.55 | -9.23 | 22.72 |
| 2025-12-08 | EOLS | -0.55 | -9.25 | 22.72 |
| 2025-12-09 | EOLS | -0.55 | -9.25 | 22.72 |
| 2025-12-10 | EOLS | -0.55 | -9.25 | 13.64 |
| 2025-12-11 | EOLS | -0.68 | -9.25 | 13.64 |
| 2025-12-12 | EOLS | -0.68 | -9.25 | 13.64 |
| 2025-12-15 | EOLS | -0.68 | -9.25 | 13.64 |
| 2025-12-16 | EOLS | -0.68 | -9.25 | 13.64 |
| 2025-12-17 | EOLS | 0.16 | -9.25 | 13.64 |
| 2025-12-18 | EOLS | 0.16 | -9.25 | 13.64 |
| 2025-12-19 | EOLS | 0.16 | -9.25 | 13.64 |
| 2025-12-22 | EOLS | 0.16 | -10.16 | 13.64 |
| 2025-12-23 | EOLS | 0.16 | -10.16 | 13.64 |
| 2025-12-26 | EOLS | 0.16 | -10.16 | 12.78 |
| 2025-12-29 | EOLS | 0.16 | -10.16 | 12.78 |
| 2025-12-30 | EOLS | 0.08 | -10.16 | 12.78 |
| 2025-12-31 | EOLS | 0.08 | -10.16 | 12.78 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.2
Avg. EPS Est. Current Quarter
0.06
Avg. EPS Est. Next Quarter
-0.07
Insider Transactions
0.08
Institutional Transactions
-10.16
Beta
0.91
Average Sales Estimate Current Quarter
90
Average Sales Estimate Next Quarter
76
Fair Value
Quality Score
30
Growth Score
51
Sentiment Score
18
Actual DrawDown %
62.6
Max Drawdown 5-Year %
-68.4
Target Price
18.5
P/E
Forward P/E
51.72
PEG
P/S
1.51
P/B
P/Free Cash Flow
EPS
-0.91
Average EPS Est. Cur. Y
-0.39
EPS Next Y. (Est.)
0.17
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-20.49
Relative Volume
0.86
Return on Equity vs Sector %
176.3
Return on Equity vs Industry %
196.4
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
36.6
Evolus, Inc. Common StockSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 329
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
stock quote shares EOLS – Evolus, Inc. Stock Price stock today
news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolus, Inc. yahoo finance google finance
stock history EOLS – Evolus, Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading